article thumbnail

Cipla Vs Sun Pharmaceutical – Financials, Future Plans & More

Trade Brains

Cipla Vs Sun Pharmaceutical : Pharma companies bear enormous responsibility for producing medicines and monetizing the time and effort spent on research and development for years by using patent protection. In this article, we will compare Cipla Vs Sun Pharmaceutical, both of which are involved in the pharmaceutical industry.

article thumbnail

Fundamental Analysis of Torrent Pharmaceuticals – Business, Financials & More

Trade Brains

Fundamental Analysis of Torrent Pharmaceuticals: Investors eye for stocks that can give consistent returns over the years, steadily rising over time like Titan Co. In this article, we perform a fundamental analysis of Torrent Pharmaceuticals to find out how it has generated impressive returns for its shareholders. Company Overview.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

: Teva Pharmaceutical announces new growth strategy built on biosimilars, innovation

MarketWatch

Teva Pharmaceutical Industries on Thursday launched a new “pivot to growth” strategy, based on existing growth drivers like Austedo and Ajovy as well as generics, further innovation, and focused capital allocation. The company expects annual sales of more than $2.5

article thumbnail

: Amneal Pharmaceuticals’ stock soars 14% premarket after company offers upbeat Q1 guidance

MarketWatch

Amneal Pharmaceuticals Inc.’s s stock AMRX soared 14% in premarket trade Monday, after the generics and specialty pharmaceuticals company offered first-quarter guidance that topped consensus estimates. Bridgewater, N.J.-based

article thumbnail

: Enanta Pharmaceuticals shares gain after RSV treatment shows positive results in early trial

MarketWatch

Shares of Enanta Pharmaceuticals Inc. ENTA gained 5% premarket on Tuesday after the biotech company released positive results from an early-phase clinical trial of a treatment for respiratory syncytial virus, or RSV.

article thumbnail

: Rocket Pharmaceuticals shares rise on FDA fast-track designation for heart disease treatment

MarketWatch

Shares of Rocket Pharmaceuticals RCKT gained 2.3% premarket on Thursday after the late-stage biotech company said the U.S. Food and Drug Administration granted fast-track and orphan-drug designations to its gene therapy candidate for treatment of an inherited heart disease.

article thumbnail

: Intercept Pharmaceuticals stock tumbles toward 11-month low after disappointing FDA committee vote

MarketWatch

Shares of Intercept Pharmaceuticals Inc. ICPT tumbled 15.2% toward an 11-month low in premarket trading Monday, after the biopharmaceutical company said a U.S. Food and Drug Administration committee voted to “defer approval” for its treatment of pre-cirrhotic fibrosis due to nonalcoholic steatohepatitis (NASH).